Disc Stem Cell Expansion for Long-Term Disc Tissue Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating intervertebral disc degeneration, such as discectomy and tissue engineering, are inadequate due to the lack of a viable source of disc stem cells that can survive and function in the harsh disc environment, and existing stem cell therapies fail to produce sufficient, functional cells for long-term regeneration.
Innovation Solution
A method for amplifying and enriching disc stem cells by culturing nucleus pulposus cells in specific growth factors and conditions, including serum, basic fibroblast growth factor (bFGF), and epidermal growth factor (EGF), to produce sphere-like clusters and aggregate clusters, thereby expanding the disc stem cell population.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If non-disc cells or nucleus pulposus cells are used for tissue engineering, then some regenerative capability is achieved, but the cells lack the appropriate gene program and division ability to sustain long-term regeneration
Solution Approach 1:
The invention extracts and isolates disc stem cells from the nucleus pulposus tissue through enzymatic digestion and density gradient centrifugation, separating the functional stem cell population from non-functional mature cells. This extraction enables obtaining cells with both regenerative capability and long-term division potential.
Solution Approach 2:
The invention changes the culture parameters by using specific growth factors (bFGF, EGF, TGF-beta), optimizing serum concentration (10-20% FBS), and controlling passage numbers to maintain stem cell characteristics. These parameter changes enable sustained long-term culture while preserving regenerative capability.
2Productivity
If mesenchymal stem cells or embryonic stem cells are used, then cell proliferation is achieved, but the cells fail to naturally reprogram to functional disc cells
Solution Approach 1:
The invention performs preliminary action by pre-differentiating mesenchymal stem cells into nucleus pulposus-like cells before implantation, using specific growth factors and culture conditions. This preliminary differentiation prepares the cells to better adapt to the disc environment and perform functional regeneration.
Solution Approach 2:
The invention uses nucleus pulposus extracellular matrix and growth factors as intermediaries to facilitate the reprogramming and differentiation of mesenchymal stem cells into functional disc cells, bridging the gap between proliferation capability and functional adaptation.
3Object-generated harmful factors
If discectomy or fusion surgery is performed, then immediate pain relief is achieved, but permanent joint disruption and chronic arthritis occur
Solution Approach 1:
The invention enables the disc tissue to repair itself by introducing disc stem cells that can differentiate into nucleus pulposus and annulus fibrosus cells, restoring the disc's natural structure and function. This self-service approach avoids permanent joint disruption while providing sustained pain relief.
Solution Approach 2:
The invention discards the need for permanent surgical interventions like fusion or artificial discs by recovering and regenerating natural disc tissue through stem cell therapy, thereby maintaining joint integrity while relieving pain.
Data Source
AI summary
This invention provides disc stem cells, processes for obtaining and culturing disc stem cells, and methods for repairing damaged or diseased disc tissue comprising the use of the disc stem cells of the invention.